Newly published research led by the Centre for Eye Research Australia (CERA) found a retinal fundus scan can accurately predict a person's risk of stroke, paving the way for non-invasive, routine test
Kicking off February's professional education, Retina NZ is inviting all ECPs to a trailblazing afternoon with renowned keynote speakers.
A meta-analysis by researchers in China has shown global myopia prevalence is anticipated to grow from a third to two-fifths of children by 2050, which they partly attributed to the effects of Covid-1
Melbourne-based tech company Cylite has developed a new hyperparallel optical coherence tomography (HP-OCT) device, capturing true volumetric 3D images of the anterior and posterior segments.
Researchers in Australia showed a novel selection pathway for multifocal intraocular lenses (mfIOLs) for cataract patients was cost-effective, with patients achieving excellent vision and self-reporte
A meta-analysis by an international team of researchers found artificial intelligence (AI)-driven deep-learning (DL) models achieved higher accuracy than ophthalmologists in diagnosing infectious kera
The phase 2b clinical trial of a contact lens (CL) containing bimatoprost and hyaluronic acid demonstrated it reduced intraocular pressure (IOP) in cases of mild to moderate glaucoma while improving p
Researchers in Japan restored a Japanese macaque’s macular hole (MH) using a human stem cell graft, which improved visual function.
A US study has revealed why some age-related macular degeneration (AMD) patients don’t respond well to anti-vascular endothelial growth factor (VEGF) treatment, suggesting a new dual-treatment approach to improve vision.
New online calculator to simplify low ocular perfusion pressure (OPP) tracking revealed
The International Agency for the Prevention of Blindness (IAPB) will host the first-ever Global Eye Health Summit in 2026, with the stated goal of bringing together world leaders to turn promises and
US researchers investigating an optogenetic therapy with “the potential to address all retinitis pigmentosa (RP) genetic variations” reported significant efficacy in a phase 2b/3 trial. Nanoscope